A detailed history of Janney Montgomery Scott LLC transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 10,000 shares of ATOS stock, worth $15,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 11,500 13.04%
Holding current value
$15,000
Previous $14,000 7.14%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$1.09 - $1.52 $1,635 - $2,280
-1,500 Reduced 13.04%
10,000 $15,000
Q2 2024

Jul 25, 2024

BUY
$1.03 - $2.1 $11,845 - $24,150
11,500 New
11,500 $14,000

Others Institutions Holding ATOS

About ATOSSA THERAPEUTICS, INC.


  • Ticker ATOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,624,000
  • Market Cap $190M
  • Description
  • Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...
More about ATOS
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.